Detrimental influences of intraluminally-administered sclerotic agents on surrounding tissues and peripheral nerves: An experimental study
暂无分享,去创建一个
K. Harii | H. Kawakami | M. Kurita | A. Takushima | M. Fujiki | N. Kaji | M. Ozaki | Mine Ozaki
[1] K. Harii,et al. Subcutaneous Injection of Normal Saline Prevents Cutaneous Complications of Ethanol Sclerotherapy for Superficial Vascular Lesions: An Experimental Study , 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[2] K. Harii,et al. Efficacy and evaluation of safety of sclerosants for intramuscular venous malformations: Clinical and experimental studies , 2010, Scandinavian journal of plastic and reconstructive surgery and hand surgery.
[3] K. Harii,et al. Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck , 2009, Scandinavian journal of plastic and reconstructive surgery and hand surgery.
[4] T. Wakefield,et al. Mechanisms of venous thrombosis and resolution. , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[5] Yuhei Yamamoto,et al. Evaluation of the Sclerotherapeutic Efficacy of Ethanol, Polidocanol, and OK‐432 Using an In Vitro Model , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[6] Yuh-Cherng Guo,et al. Facial nerve conduction after sclerotherapy in children with facial lymphatic malformations: report of two cases. , 2007, The Tohoku journal of experimental medicine.
[7] A. Hirano,et al. Therapeutic Choice for Craniofacial Venous Malformations , 2006, The Journal of craniofacial surgery.
[8] D. Freedman,et al. An injectable tissue-engineered embolus prevents luminal recanalization after vascular sclerotherapy. , 2005, Journal of pediatric surgery.
[9] F. Allaert,et al. Immediate and Midterm Complications of Sclerotherapy: Report of a Prospective Multicenter Registry of 12,173 Sclerotherapy Sessions , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[10] C. Mounayer,et al. Percutaneous sclerotherapy for venous malformation of the lips: a retrospective study of 23 patients , 2000, Neuroradiology.
[11] J. Mulliken,et al. Sclerotherapy of craniofacial venous malformations: complications and results. , 1999, Plastic and reconstructive surgery.
[12] L. Cantley,et al. Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2 , 1996, Cell.
[13] L. Greenfield,et al. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[14] A. D. Lorimier,et al. Sclerotherapy for venous malformations. , 1995, Journal of pediatric surgery.
[15] G. Sebag,et al. Soft-tissue venous malformations in children: percutaneous sclerotherapy with Ethibloc. , 1991, Radiology.
[16] K. Orikasa. [Studies on the damage of the cultured endothelial cells and K-562 cells by sclerosants (ethanolamine oleate, Aethoxysklerol and absolute ethanol) used in the treatment of esophageal varices]. , 1989, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.
[17] J. Michael. Textbook of Medical Physiology , 2005 .